1. The Global Fund:
A Public-private Partnership to
Fight Deadly Diseases
Professor Rifat Atun
Director, Strategy, Performance and Evaluation Cluster

2. Presentation Structure
• Global Health Public Private Partnerships
• Segmentation
• The Global Fund

3. Total annual resources available for
AIDS: 1986-2008
13 13
12
11
10
10
9
8297
Signing 2001 UN
8
US$ Billion
Declaration of Commitment
7 on HIV/AIDS (UNGASS )
6
5
World Bank
4 MAP launch
UNAIDS PEPFAR
3 Less than
US$ 1 million
2
1623 Global Fund
212 257 292
1 59
0
1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Notes: [1] 1986-2000 figures are for international funds only [2] Domestic funds are included from 2001 onwards

4. Global Health Partnerships
Almost 100 in number
• New actors in the global health landscape
– Country governments (donors and recipients), philanthropy (e.g.
Gates), Private Sector, Pharma, Med Tech and Civil Society
• New global governance mechanisms
– Transcend traditional multilateral institutions

5. Investment in GHPPP (received) by 2007
Foundations – Multilateral Agencies - Private
Governments
12000
10000
8000
6000
4000
US$ Millions
2000
250
200
150
100
50
0
ip
ip
ce
sh
S
TM
l
er H
sh
P
i
I
er I
TH
ta
I
V
D
I
A R
M
D
V
tn V
A
R
V
tn W
an
A
M
N
D
To
IP
A
N
ar D
R
M
ID
FA
H
A
a rIO
FI
TB T
M
lli
G
P P
D
E
C
P
A
G
A
P
B
TB
-T
R
p
D
to
M
S
ll y
Li

6. • Global Health Public Private Partnerships
• Segmentation
• The Global Fund

7. Segmenting Global Health PPPs (1)

8. Segmenting Global Health PPPs (2)

9. Push Mechanisms: Product Development
Partnerships
• Global Alliance for TB Drug Development (TB
Alliance)
• International AIDS Vaccine Initiative (IAVI)
• International Partnership for Microbicides (IPM)
• Malaria Vaccine Initiative (MVI)
• Medicines for Malaria Venture (MMV)
• Microbicide Development Programme (MDP)

10. Number of GHPPP along the R&D value
chain

11. Number of GHPPPs along the R&D value
chain by disease area

12. Push Mechanisms: Product Access
Partnerships
• Global Alliance for the Elimination of Lymphatic
Filariasis
• Global Polio Eradication Initiative (GPEI)
• International Trachoma Initiative (ITI)
• Malarone Donation Program
• Mectizan Donation Program
• WHO/Novartis Coartem® (Coartem)

13. Pull Mechanisms: Global Financing
Institutions
• The Global Fund to Fight AIDS, Tuberculosis and
Malaria (The Global Fund)
• Global Alliance for Vaccines and Immunization
(GAVI Alliance)

14. • Global Health Public Private Partnerships
• Segmentation
• The Global Fund

15. Scaling up in investment
By September 2009 Proportion of External
Global Investment (2008)
• Total pledges $21.2 Bn • 23% of HIV
• Approved ~ $16.2 Bn • 60% of TB
• Disbursed ~ $8.6 Bn • 75% of Malaria
(142 countries and ~ 600
grants)

17. Accelerating Scale Up
5.0 75
70
4.5 DOTS
65
ARV
4.0 60
ITNs
ARV and DOTS (millions)
55
3.5
50
3.0 45
ITN (millions)
40
2.5
35
2.0 30
25
1.5
20
1.0 15
10
0.5
5
0.0 -
2004 2005 2006 2007 2008

19. Affordable Medicines Facility – malaria
Multiple eligible Co-payment
ACT manufacturers
First line Private NGO Buyers Public Buyers
buyers Buyers (e.g. PSI, MSF) (e.g. Ministry of
(e.g. National Health)
Wholesalers)
Wholesalers Distributors Central medical
stores Medicines
Money
Retailers, private
clinics and public
providers
Patients